217 related articles for article (PubMed ID: 11167322)
21. Magnetic resonance angiography without contrast enhancement medium in bone and soft tissue tumors.
Doi H; Ono A; Kawai A; Morimoto Y; Kunisada T; Nakata E; Ozaki T
Oncol Rep; 2006 Mar; 15(3):681-5. PubMed ID: 16465430
[TBL] [Abstract][Full Text] [Related]
22. MR imaging of malignant soft-tissue tumors.
Hanna SL; Fletcher BD
Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):629-50. PubMed ID: 8564687
[TBL] [Abstract][Full Text] [Related]
23. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.
Pawlik TM; Pisters PW; Mikula L; Feig BW; Hunt KK; Cormier JN; Ballo MT; Catton CN; Jones JJ; O'Sullivan B; Pollock RE; Swallow CJ
Ann Surg Oncol; 2006 Apr; 13(4):508-17. PubMed ID: 16491338
[TBL] [Abstract][Full Text] [Related]
25. MR imaging differentiation of soft-tissue hemangiomas from malignant soft-tissue masses.
Teo EL; Strouse PJ; Hernandez RJ
AJR Am J Roentgenol; 2000 Jun; 174(6):1623-8. PubMed ID: 10845496
[TBL] [Abstract][Full Text] [Related]
26. Dynamic MR imaging of soft tissue tumors with assessment of the rate and character of lesion enhancement.
Tacikowska M
Med Sci Monit; 2002 Feb; 8(2):MT31-5. PubMed ID: 11859289
[TBL] [Abstract][Full Text] [Related]
27. Advances in MR imaging of pediatric musculoskeletal neoplasms.
Lang P; Johnston JO; Arenal-Romero F; Gooding CA
Magn Reson Imaging Clin N Am; 1998 Aug; 6(3):579-604. PubMed ID: 9654586
[TBL] [Abstract][Full Text] [Related]
28. Histologic assessment of peritumoral edema in soft tissue sarcoma.
White LM; Wunder JS; Bell RS; O'Sullivan B; Catton C; Ferguson P; Blackstein M; Kandel RA
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1439-45. PubMed ID: 15817348
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
Zhou ZR; Shen TZ; Chen XR; Peng WJ
Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
[TBL] [Abstract][Full Text] [Related]
30. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
31. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
32. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
33. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of magnetic resonance imaging in determining presence of residual disease after marginal excision of unsuspected soft tissue sarcomas of the hand.
Puhaindran ME; Pratt J; Manoso MW; Healey JH; Mintz DN; Athanasian EA
J Hand Surg Am; 2010 Sep; 35(9):1479-84. PubMed ID: 20807625
[TBL] [Abstract][Full Text] [Related]
36. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
Stacchiotti S; Collini P; Messina A; Morosi C; Barisella M; Bertulli R; Piovesan C; Dileo P; Torri V; Gronchi A; Casali PG
Radiology; 2009 May; 251(2):447-56. PubMed ID: 19261927
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences.
Soldatos T; Ahlawat S; Montgomery E; Chalian M; Jacobs MA; Fayad LM
Radiology; 2016 Mar; 278(3):831-40. PubMed ID: 26390048
[TBL] [Abstract][Full Text] [Related]
38. [Magnetic resonance in the diagnosis and follow-up of soft-tissue sarcomas].
Marano I; Brunetti A; Covello M; Belfiore G; Giovine S; Salvatore M
Radiol Med; 1992; 84(1-2):15-21. PubMed ID: 1509133
[TBL] [Abstract][Full Text] [Related]
39. The role of MR imaging in soft tissue tumor evaluation: perspective of the orthopedic oncologist and musculoskeletal pathologist.
Frassica FJ; Khanna JA; McCarthy EF
Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):915-27. PubMed ID: 11149686
[TBL] [Abstract][Full Text] [Related]
40. The use of gadolinium in the MR evaluation of musculoskeletal tumors.
Kransdorf MJ
Top Magn Reson Imaging; 1996 Feb; 8(1):15-23. PubMed ID: 8820091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
